17 May 2002
The Prozac boom and its placebogenic counterpart -- a culturally fashioned phenomenon.
Brian Taylor SlingsbyMed Sci Monit 2002; 8(5): CR389-393 :: ID: 420826
Abstract
BACKGROUND: The placebo effect describes the mind-body process of alteringthe body's physiological state as well as the brain's neurological state. Catalyzed by the mind's believingin a certain drug, ritual, and/or treatment, it generally refers to the phenomenon of an ill individualrecovering to health. Subsequent to the Prozac boom (fluoxetine), which occurred during the 1980s and90s in the United States, a new form of placebogenic phenomena was defined: 'cosmetic psychopharmacology',whereby the healthy individual is transformed to fit better in his/her cultural medium (defined by one'svalues and beliefs). In order to discover how cultural metaphors (e.g. media-generated symbolism, socialideals) influence psychopharmacological treatment, this report investigates the following questions:Is the Prozac Boom culturally fashioned? Is cosmetic psychopharmacology culturally fashioned? Are cosmeticpsychopharmacology and its ability to better the individual (relative to American ideals) a placebogenicphenomenon? MATERIAL/METHODS: The data and speculation for the present report was obtained via a culturaland critical review. RESULTS: It would appear that (1) the Prozac Boom and subsequently its by product,cosmetic psychopharmacology, are culturally fashioned; (2) cosmetic psychopharmacology is consideredto result from one's belief in a drug and thus is placebo-influenced. CONCLUSIONS: Media-generated symbolism,which represents and reciprocally fashions the ideals and values of that society, influence the socialperceptions of a drug's effectiveness and the quality of a particular treatment. In the clinical setting,the influential role of these preconceived notions about a certain treatment and/or drug need to be furtherconsidered and studied.
Keywords: Depressive Disorder, fluoxetine, Placebo Effect, Psychology, Psychopharmacology, Research Support, Non-U.S. Gov, Social Perception
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952